» Articles » PMID: 34691283

Association Between Congenital Cytomegalovirus Infection and Brain Injury in Neonates: A Meta-analysis of Cohort Studies

Overview
Journal Behav Neurol
Publisher Wiley
Specialty Psychiatry
Date 2021 Oct 25
PMID 34691283
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess association between congenital cytomegalovirus (CMV) infection and brain injury in neonates.

Methods: The literatures from inception to November 4, 2020, were searched through PubMed, Embase, Cochrane Library, and Web of Science. Heterogeneity test was conducted for each indicator and measured by statistics. If ≥ 50%, the random effects model was applied; otherwise, the fixed effects model was used. Sensitivity analysis was performed for all models. Weighed mean difference (WMD) was used as the effect size for measurement data, and risk ratio (RR) was as the effect indicator.

Results: A total of 13 studies, including 4,262 congenital CMV infection neonates, were enrolled in this study. Our results showed that the rate of hearing impairment (RR: 2.105, 95% CI: (1.115, 3.971), = 0.002), sensorineural hearing loss (SNHL) (RR: 17.051, 95% CI: (6.201, 46.886), < 0.001), and microcephaly (RR: 2.283, 95% CI: (1.325, 3.935),  =0.003) in neonates infected congenital CMV was higher than that in control group.

Conclusion: The risks of hearing impairment, SNHL, and microcephaly in neonates during childhood may be associated with congenital CMV infection. It is necessary to establish neonatal screening programs and comprehensive diagnostic tests for patients to reduce the risk of adverse brain damage to the congenital CMV infection as early as possible and to improve the prognosis of the newborn.

Citing Articles

Cytomegalovirus and Pregnancy: A Narrative Review.

Pontes K, Nardozza L, Peixoto A, Werner H, Tonni G, Granese R J Clin Med. 2024; 13(2).

PMID: 38276146 PMC: 10816506. DOI: 10.3390/jcm13020640.


A systematic review of immune-based interventions for perinatal neuroprotection: closing the gap between animal studies and human trials.

Kelly S, Tran N, Polglase G, Hunt R, Nold M, Nold-Petry C J Neuroinflammation. 2023; 20(1):241.

PMID: 37864272 PMC: 10588248. DOI: 10.1186/s12974-023-02911-w.


Adipokines as Diagnostic and Prognostic Markers for the Severity of COVID-19.

Grewal T, Buechler C Biomedicines. 2023; 11(5).

PMID: 37238973 PMC: 10215701. DOI: 10.3390/biomedicines11051302.

References
1.
Dreher A, Arora N, Fowler K, Novak Z, Britt W, Boppana S . Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 2014; 164(4):855-9. PMC: 3982912. DOI: 10.1016/j.jpeds.2013.12.007. View

2.
Yamamoto A, Mussi-Pinhata M, Isaac M, Amaral F, Carvalheiro C, Aragon D . Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J. 2011; 30(12):1043-6. PMC: 3222783. DOI: 10.1097/INF.0b013e31822d9640. View

3.
Dollard S, Grosse S, Ross D . New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007; 17(5):355-63. DOI: 10.1002/rmv.544. View

4.
Boppana S, Rivera L, Fowler K, Mach M, Britt W . Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001; 344(18):1366-71. DOI: 10.1056/NEJM200105033441804. View

5.
Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I . Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014; 134(5):972-82. DOI: 10.1542/peds.2014-1173. View